Back to companies
Bolt Biotherapeutics, Inc.
BOLTUSNASDAQPharmaceuticals & HealthcareBolt Biotherapeutics, Inc.
Revenue
$7.7mn
YoY +0.1%
Operating income
-$36.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API